Rivaroxaban Seems Safe, Effective for Pediatric Acute VTE

Imprensa/meios de comunicação: Other

Período14 nov 2019

Media contributions

1

Media contributions

  • TítuloRivaroxaban Seems Safe, Effective for Pediatric Acute VTE
    Grau de reconhecimentoInternational
    Nome/saída de meios de comunicaçãoMedscape WebMD LLC
    Tipo de meios de comunicaçãoWeb
    PaísUnited States
    Data14/11/2019
    DescriçãoNEW YORK (Reuters Health) - In children with acute venous thromboembolism (VTE), treatment with the direct oral anticoagulant rivaroxaban results in a similarly low recurrence risk and a lower thrombotic burden as parenteral anticoagulants, without increasing bleeding, researchers say.
    Fabricante/AutorMarilynn Larkin
    URLhttps://www.medscape.com/viewarticle/921241
    PessoasОльга Александровна Львова